Article
The CCR2 promoter polymorphism T-960A, but not the serum MCP-1 level, is associated with endothelial function in prediabetic individuals.
Atherosclerosis - 1 Jun 2008
Rittig Kilian, Peter Andreas, Baltz Katrin M, Tschritter Otto, Weigert Cora, Andreozzi Francesco, Perticone Francesco, Siegel-Axel Dorothea I, Stefan Norbert, Fritsche Andreas, Salih Helmut R, Schleicher Erwin, Machicao Fausto, Sesti Giorgio, Häring Hans-Ulrich, Balletshofer Bernd M
Abstract excerpt
Monocyte-chemoattractant-protein (MCP)-1 and its receptor CCR2 have been shown to play a pivotal role in vascular inflammation and atherosclerotic plaque formation. However, it is currently unclear whether MCP-1/CCR2 triggered inflammation affects nitric oxide (NO)-bioavailability, hence influencing vascular function, a sign of early atherosclerosis. Therefore, we sought to investigate the association between...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
